The ESP and BDIAP gratefully acknowledge the support of the following companies for the 32nd Congress of the ESP and the XXXIII International Congress of the IAP: 

Premium Sponsor

AstraZeneca (Privacy Policy)

Major Sponsors

Bristol Myers Squibb (Privacy Policy)

Main Sponsor

Thermo Fisher Scientific (Privacy Policy)

Further Sponsors and Exhibitors

Agilent Technologies (Privacy Policy)
Aiforia (Privacy Policy)
ArcherDX (Privacy Policy)


ContextVision AB (Privacy Policy)

Daiichi Sankyo Europe GmbH

Daiichi Sankyo is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address unmet medical needs. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees draw upon a rich legacy of innovation and a robust pipeline of promising new medicines.

Our 2025 Vision is to become a “Global Pharma Innovator with Competitive Advantage in Oncology”. Anchored by our DXd antibody drug conjugate (ADC) technology, our powerful research engines include biologics, medicinal chemistry, modality and other research laboratories. More information: (Privacy Policy)
Epredia (Privacy Policy)
EXACT SCIENCES (Privacy Policy)
Ibex Medical Analytics (Privacy Policy)
Innovative Science Press (Privacy Policy)
Lunaphore (Privacy Policy)
Merck KGaA (Privacy Policy
MILSTONE S.r.l. (Privacy Policy)
Myriad Genetics (Privacy Policy)
Nanostring Technologies (Privacy Policy)
Novartis (Privacy Policy)
Novodiax (Privacy Policy)
Olympus (Privacy Policy)
Paige (Privacy Policy)
Philips (Privacy Policy)
Primera Technology, Inc. (Privacy Policy)
Roche (Privacy Policy)
Visiopharm A/S (Privacy Policy)
WILEY (Privacy Policy)